BiotechTube
Home/Abarceo Pharma/Adam Bruce
AB

Adam Bruce

CEO

Abarceo Pharma

Therapeutic Areas

OncologyMetabolic DiseaseCardiovascular DiseaseNeurodegenerative Disease

Abarceo Pharma Pipeline

DrugIndicationPhase
VDAC1 PlatformType 2 DiabetesPreclinical

Leadership Team at Abarceo Pharma

CW
Claes Wollheim, MD
Scientific Founder, Senior Scientific Leader
AS
Albert Salehi
Scientific Founder
View full Abarceo Pharma profile